DEXora
AI-Driven Molecular Discovery Platform
Pioneering the next generation of computational pharmacology — a clinical-grade platform combining machine learning activity predictions, automated binding validation, and molecular dynamics to accelerate drug research from target to lead.
The House of DEXora
Six integrated pillars powering the future of pharmaceutical formulation and molecular design — from prediction to validation.
MLDex
AI/ML-based prediction of active-like, drug-like, and hit-like molecules using advanced molecular descriptors.
LeadDex
Virtual screening from PubChem, ZINC, ChEMBL, DrugBank, natural product, and in-house databases.
DeNovoDex
AI-based generation of entirely novel molecules from scratch with custom property constraints.
DockDex
Molecular docking and binding validation with automated pocket-binding affinity estimation.
ADMETDex
ADMET, drug-likeness, and toxicity prediction — evaluating chemical safety profiles and rule violations.
DynoDex
Molecular dynamics simulation and stability analysis for conformational validation.
Built by Two Visionaries
DEXora is born from the intersection of pharmaceutical science expertise and cutting-edge software engineering — each partner contributing their core strengths.
Thathwamasi Global Solutions
Innovating Products for Pharmaceutical Science, Research & Global Healthcare
- Pharmaceutical Domain Expertise
- Computational Pharmacology Research
- Drug Discovery Workflows
- Molecular Property Validation
BestWay Solution
Software for All. You Dream It. We Build It.
- Software Architecture & Engineering
- AI/ML Model Development
- Cloud Infrastructure & Scalability
- Data Security & Pipeline Design